171
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 2033-2045 | Published online: 25 May 2020

References

  • StanleyTH, EganTD, Van AkenH. A tribute to Dr. Paul AJ Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg. 2008;106(2):451–462. doi:10.1213/ane.0b013e3181605add18227300
  • StanleyTH. The fentanyl story. J Pain. 2014;15(12):1215–1226. doi:10.1016/j.jpain.2014.08.01025441689
  • BaileyP, StanleyT. Opioid Action and Sensory Evoked Potentials. By Miller RD. New York: Churchill Livingstone; 1994:320.
  • KatheK, KathpaliaH. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 2017;12(6):487–497. doi:10.1016/j.ajps.2017.07.00432104362
  • ZeppetellaG. An assessment of the safety, eff icacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage. 2000;20(4):253–258. doi:10.1016/S0885-3924(00)00180-911027906
  • BredenbergS, DubergM, LennernäsB, et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Hosp Pharm. 2003;20(3):327–334. doi:10.1016/j.ejps.2003.07.002
  • MandelL, CarunchioMJ. Rampant caries from oral transmucosal fentanyl citrate lozenge abuse. J Am Dent Assoc. 2011;142(4):406–409. doi:10.14219/jada.archive.2011.019521454846
  • LambropoulosJ, SpanosGA, LazaridisNV, et al. Development and validation of an HPLC assay for fentanyl and related substances in fentanyl citrate injection, USP. J Pharm Biomed Anal. 1999;20(4):705–716. doi:10.1016/S0731-7085(99)00077-110704140
  • PayneR, ColuzziP, HartL, et al. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage. 2001;22(1):575–583. doi:10.1016/S0885-3924(01)00306-211516599
  • Abuse, N.I.o.D. Overdose Death Rates. Bethesda, MD: NIDA; 2017.
  • ChandlerS. Symptoms of an Opiate Overdose. Live Strong; 5 17, 2012.
  • BernardsCM, LugerT, MalmbergAB, et al. Liposome encapsulation prolongs alfentanil spinal analgesia and alters systemic redistribution in the rate. Anesthesiology. 1992;77(3):529–535. doi:10.1097/00000542-199209000-000191519790
  • WallaceMS, YanezAM, HoRJ, ShenDD, YakshTL. Antinociception and side effects of liposome-encapsulated alfentanil after spinal delivery in rats. Anesth Analg. 1994;79(4):778–786. doi:10.1213/00000539-199410000-000287943792
  • IsacksonJ, MllaceMS, HoRJY, ShedDD, YakshTL. Antinociception and side effects of L-and D-dipalmitoylphosphatidyl choline liposome-encapsulated alfentanil after spinal delivery in rats. Pharmacol Toxicol. 1995;77:333–340. doi:10.1111/j.1600-0773.1995.tb01037.x8778746
  • SoutoE, AlmeidaA, MüllerR. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol. 2007;3(4):317–331. doi:10.1166/jbn.2007.049
  • HatefiL, FarhadianN. A safe and efficient method for encapsulation of ferrous sulfate in solid lipid nanoparticle for non-oxidation and sustained iron delivery. Colloid Interface Sci Commun. 2020;34:100227. doi:10.1016/j.colcom.2019.100227
  • ZhuangC-Y, LiN, WangM, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1–2):179–185. doi:10.1016/j.ijpharm.2010.05.00520471464
  • EbrahimiS, FarhadianN, KarimiM, EbrahimiM. Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study. Antimicrob Resist Infect Control. 2020;9(1). doi:10.1186/s13756-020-0690-4
  • PezeshkiA, GhanbarzadehB, MohammadiM, et al. Encapsulation of vitamin A palmitate in nanostructured lipid carrier (NLC)-effect of surfactant concentration on the formulation properties. Adv Pharm Bull. 2014;4(Suppl 2):563. doi:10.5681/apb.2014.04725671190
  • SaporitoF, SandriG, BonferoniMC, et al. Essential oil-loaded lipid nanoparticles for wound healing. Int J Nanomedicine. 2018;13:175. doi:10.2147/IJN.S15252929343956
  • LacatusuI, ArsenieLV, BadeaG, et al. New cosmetic formulations with broad photoprotective and antioxidative activities designed by amaranth and pumpkin seed oils nanocarriers. Ind Crops Prod. 2018;123:424–433. doi:10.1016/j.indcrop.2018.06.083
  • HuF-Q, JiangS-P, DuY-Z, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 2005;45(3–4):167–173. doi:10.1016/j.colsurfb.2005.08.00516198092
  • PardeikeJ, WeberS, HaberT, et al. Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm. 2011;419(1–2):329–338. doi:10.1016/j.ijpharm.2011.07.04021839157
  • AndersonC, MacKayM. Stability of fentanyl citrate, hydromorphone hydrochloride, ketamine hydrochloride, midazolam, morphine sulfate, and pentobarbital sodium in polypropylene syringes. Pharmacy. 2015;3(4):379–385. doi:10.3390/pharmacy304037928975923
  • PongpeerapatA, ItohK, TozukaY, et al. Formation and stability of drug nanoparticles obtained from drug/PVP/SDS ternary ground mixture. J Drug Deliv Sci Technol. 2004;14(6):441–447. doi:10.1016/S1773-2247(04)50082-5
  • DubuissonD, DennisSG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain. 1977;4:161–174. doi:10.1016/0304-3959(77)90130-0564014
  • MyersRH, MontgomeryDC, ViningGG, et al. Response surface methodology: a retrospective and literature survey. J Qual Technol. 2004;36(1):53–77. doi:10.1080/00224065.2004.11980252
  • HaalandPD. Experimental Design in Biotechnology. United State of America: Marcel Dekker. Inc; 1989.
  • ChauhanB, GuptaR. Application of statistical experimental design for optimization of alkaline protease production from Bacillus sp. RGR-14. Process Biochem. 2004;39(12):2115–2122. doi:10.1016/j.procbio.2003.11.002
  • LiH, QiaoH, LuH, et al. Evaluation of the peripheral analgesic effect of sufentanil lipid nanoparticles. J Anesth. 2014;28(5):702–707. doi:10.1007/s00540-014-1795-924604021
  • ZeashanH, AmreshG, RaoCV, et al. Antinociceptive activity of Amaranthus spinosus in experimental animals. J Ethnopharmacol. 2009;122(3):492–496. doi:10.1016/j.jep.2009.01.03119429318
  • BahramiMA, FarhadianN. Experimental study and mathematical modeling for encapsulation of fentanyl citrate drug in nanostructured lipid carrier. Biomol Struct Dyn. 2020;38:1263–1271. doi:10.1080/07391102.2019.1599732